5th Annual MarketsandMarkets

Real-World Evidence and Life Sciences Analytics Conference

20th-21st October 2022

Hilton Boston Logan Airport

MarketsandMarkets is proud to announce the 5th Annual Real-World Evidence and Life Sciences Conference to be held on October 20-21, 2022 in Boston, USA.

Real-world data and real-world evidence are poised to keep making strides in 2022.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.

Shifts in healthcare coverage and provision during the pandemic have changed the discovery and reporting of certain outcomes in data and the treated population. This means that disease trends may lead to incorrect interpretations when RWD and RWE are not framed in the context of the pandemic and long-term COVID-19 disease, therapy, and lifestyle changes. Telemedicine and virtual care may also provoke a greater adoption of technologies such as wearables and digital therapeutics, thus accelerating digitalization in the healthcare space and boosting the importance of RWE and AI.

Additionally with the new guidance by the FDA around data quality and data standards, the stakeholders are seeking to learn its long term impact and safety surveillance. This conference will focus on above said significant points and hold discussions on the best practices adopted by various stakeholders with a key takeaway being better decision making.

WHAT TO EXPECT

  • Regulatory view around data quality & data standards.
  • Leveraging RWE for improving market access.
  • The adoption & role of AI & ML in clinical trials.
  • Real-world evidence & Digital Health - The expanded role of RWE for digital health.
  • Panel Discussion on lessons learned from the recent results of the FDA’s
    pilot program RCT DUPLICATE.
  • Real-World Data & Advanced Analytics.
  • RWE to inform decision making process in rare diseases where there is lack of evidence.

  • Learn about the recent trends and advancements in Real-World Evidence Generation
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers

From pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-

Real-World Evidence, Real-World Data, Health Economics & Outcomes Research- HEOR, Market Access/Value Access, Clinical Outcomes, Clinical Development & research, Clinical trial and others

CONFERENCE AGENDA

Registration

08:15 - 08:55

Welcome note from MarketsandMarkets!

08:55 - 09:00

Opening Remarks from the Chairman

Prasun Mishra

Prasun Mishra, Founding Director, Chairman of the Board, Agility Pharmaceuticals

09:00 - 09:05

Demonstrating Drug Value to Enable Efficient Reimbursement

Charles Makin

Charles Makin , Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen

09:05 - 09:40

Strategies for leveraging Real-World Data in the Pharmaceutical Landscape

Sunil Dravida

Sunil Dravida, Global Head of RWD Center of Excellence,, Takeda

09:40 - 10:15

Delivering on the Promise of RWD to Advance Health Equity: Opportunities, Challenges and Case Studies

Jessica Paulus

Jessica Paulus, VP of Research, OM1,Inc

10:15 - 10:50

Morning Refreshments | One-to-One Networking Meetings

10:50 - 11:40

Using RWE in Drug Development Pipeline

Xiaoyun (Lucy) Pan

Xiaoyun (Lucy) Pan, Senior Director, Oncology Real World Evidence, Bayer

11:40 - 12:15

Integrated Data – Greater than the sum of its parts?

Nathan Hill

Nathan Hill, Director, Real World Evidence Strategy and Innovations, BMS

12:15 - 12:50

Let’s Get Direct: How working directly with patients optimizes delivery of complete RWD

Kristen Hahn

Kristen Hahn, PhD, MPH Head of RWE Research, Picnic Health

12:50 - 13:25

Lunch | One-to-One Networking Meetings

13:25 - 14:25

Real World Data and Precision Medicine

Jennifer Webster

Jennifer Webster, Senior Director, RWE Scientist Oncology Team Lead, Pfizer

14:25 - 15:00

How Artificial Intelligence is Enhancing Real-World Data, Evidence, and the future of Precision Medicine

Prasun Mishra

Prasun Mishra, Founding Director, Chairman of the Board, Agility Pharmaceuticals

15:00 - 15:35

How to Leverage RWE to Improve Market Access and to Inform Decision Making Process

Huan Huang

Huan Huang, Senior Director, Healh Economics & Outcomes Research (HEOR), G1 Therapeutics, USA

15:35 - 16:10

Breakout Session: Precision Medicine: The Way Forward!

Prasun Mishra

Prasun Mishra, Founding Director, Chairman of the Board, Agility Pharmaceuticals

16:10 - 16:45

Closing remarks from the chairperson!

Prasun Mishra

Prasun Mishra, Founding Director, Chairman of the Board, Agility Pharmaceuticals

16:45 - 16:45

Drinks Reception and Networking | Evening Refreshments

16:45 - 16:45

End of Day 1

16:45 - 16:45

Registration

08:15 - 08:55

Welcome Note from MarketsandMarkets!

08:55 - 09:00

Opening Remarks from the Chairman!

Andrew Stewart

Andrew Stewart, Head of RWE and Behavioral Science - Consumer Healthcare, Sanofi

09:00 - 09:05

The Importance of Metadata Quality and Completeness for Real World Evidence and Insight Generation

Jennifer Webster

Jennifer Webster, Senior Director, RWE Scientist Oncology Team Lead, Pfizer

09:05 - 09:40

Strategic use RWE to Address Uncertainty Related to Decision Making in Rare Disease

Joel Iff

Joel Iff, Senior Director Global Market Access, Sarepta Therapeutics, USA

09:40 - 10:15

Morning Refreshments | One-to-One Networking Meetings

10:15 - 11:05

PANEL DISCUSSION: Lessons learned from the recent results of the FDA’s pilot program RCT- DUPLICAT

11:05 - 11:50

How Science, Technology, and Regulations are Converging to Transform the Role of RWE in Healthcare Decision-Making

Vishvas Garg

Vishvas Garg, Sr. Director, TA Lead, HEOR, AbbVie

11:50 - 12:25

Understanding the patient/payer perspective: Making evidence relevant

Andrew Stewart

Andrew Stewart, Head of RWE and Behavioral Science - Consumer Healthcare, Sanofi

12:25 - 13:00

Closing remarks from the chairperson

Andrew Stewart

Andrew Stewart, Head of RWE and Behavioral Science - Consumer Healthcare, Sanofi

13:00 - 13:00

Lunch | One-to-One Networking Meetings

13:00 - 14:00

End of Conference

14:00 - 14:00

CONFERENCE SPEAKERS

ADVISORS

Charles Makin

Charles Makin

Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen

Nneka Onwudiwe

Nneka Onwudiwe

Former PRO/PE Regulatory Review Officer, FOOD AND DRUG ADMINISTRATION

Joel Iff

Joel Iff

Senior Director Global Market Access, Sarepta Therapeutics, USA

Melva Covington

Melva Covington

Principal, AGAPE Strategic Solutions LLC

SPEAKERS

Charles Makin

Charles Makin

Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen

Nneka Onwudiwe

Nneka Onwudiwe

Former PRO/PE Regulatory Review Officer, FOOD AND DRUG ADMINISTRATION

Joel Iff

Joel Iff

Senior Director Global Market Access, Sarepta Therapeutics, USA

Melva Covington

Melva Covington

Principal, AGAPE Strategic Solutions LLC

Huan Huang

Huan Huang

Senior Director, Healh Economics & Outcomes Research (HEOR), G1 Therapeutics, USA

Jennifer Webster

Jennifer Webster

Senior Director, RWE Scientist Oncology Team Lead, Pfizer

Sunil Dravida

Sunil Dravida

Global Head of RWD Center of Excellence,, Takeda

Nathan Hill

Nathan Hill

Director, Real World Evidence Strategy and Innovations, BMS

Prasun Mishra

Prasun Mishra

Founding Director, Chairman of the Board, Agility Pharmaceuticals

Xiaoyun (Lucy) Pan

Xiaoyun (Lucy) Pan

Senior Director, Oncology Real World Evidence, Bayer

Jessica Paulus

Jessica Paulus

VP of Research, OM1,Inc

Kristen Hahn

Kristen Hahn

PhD, MPH Head of RWE Research, Picnic Health

Andrew Stewart

Andrew Stewart

Head of RWE and Behavioral Science - Consumer Healthcare, Sanofi

Vishvas Garg

Vishvas Garg

Sr. Director, TA Lead, HEOR, AbbVie

ENQUIRE NOW

SPONSORS

PARTNERS

LOCATION

Venue

Hilton Boston Logan Airport

PAST EVENT GALLERY